Coverart for item
The Resource Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa

Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa

Label
Anticoagulants, antiplatelets, and thrombolytics
Title
Anticoagulants, antiplatelets, and thrombolytics
Statement of responsibility
edited by Shaker A. Mousa
Contributor
Subject
Language
eng
Summary
"During the past decade, remarkable progress has been made in the development of new drugs to treat thrombotic and cardiovascular diseases, the number one cause of mortality worldwide. In Anticoagulants, Antiplatelets, and Thrombolytics, leading experts with established records of discovery and invention highlight the latest developments in antithrombotics and provide experimental methods for the discovery of new and improved anticoagulants. Among the cutting-edge developments reviewed are the novel usage of low molecular weight heparins, such antithrombin agents as hirudin, and such antiplatelet drugs as the GPIIb/IIIa inhibitors and ADP-receptor antagonists. Additional innovations discussed include aspirin and clopidogrel, the expanded use of polytherapeutic approaches, antiproteases (factors IIa, Xa, and VIIa), tissue-factor targeting, platelet-receptor targeting, and antithrombin III modulation. The authors also define the clinically relevant in vitro and in vivo models of thrombosis and hemostasis that led to these advances and that will surely aid in the discovery of the next generation of antithrombotics. Up-to-date and forward-looking, Anticoagulants, Antiplatelets, and Thrombolytics illuminates the latest developments in the field of thrombosis and provides both basic and clinical investigators a broad array of successful experimental methods for the discovery and development of novel drugs to treat thrombotic and cardiovascular diseases. Book jacket."--Jacket
Member of
Is part of
Cataloging source
COO
Dewey number
615/.718
Illustrations
illustrations
Index
index present
Language note
English
LC call number
RM340
LC item number
.A566 2004
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
  • W1
  • QZ 170
NLM item number
  • ME9616JM v.93 2003
  • A629 2003
http://library.link/vocab/relatedWorkOrContributorName
Mousa, Shaker A
Series statement
Methods in molecular medicine
Series volume
93
http://library.link/vocab/subjectName
  • Anticoagulants (Medicine)
  • Blood platelets
  • Thrombolytic therapy
  • Fibrinolytic agents
  • Anticoagulants
  • Thrombolytic Therapy
  • Fibrinolytic Agents
  • Heparin
  • Platelet Aggregation Inhibitors
  • Thrombocytopenia
  • MEDICAL
  • Anticoagulants (Medicine)
  • Blood platelets
  • Fibrinolytic agents
  • Thrombolytic therapy
  • Anticoagulantia
  • Antitrombotica
  • Bloedplaatjes
  • Wetenschappelijke technieken
Label
Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Highlights of latest advances in antithrombotics / S.A. Mousa -- Antiplatelet, anticoagulant, and thrombolytic drug interactions / O. Iqbal and S.A. Mousa -- Evaluation of platelet antagonists in in vitro flow models of thrombosis / O.J. McCarty [and others] -- Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases / S.A. Mousa -- Are low molecular weight heparins the same? / S.A. Mousa -- Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia / W.P. Jeske and J.M. Walenga -- Laboratory methods for heparin-induced thrombocytopenia / M. Prechel, W.P. Jeske and J.M. Walenga -- Factor Xa inhibitors / J.M. Walenga [and others] -- Tissue factor/VIIa in thrombosis and cancer / S.A. Mousa -- Tissue factor pathway inhibitor in thrombosis and beyond / S.A. Mousa [and others] -- Cell adhesion molecules: potential therapeutic and diagnostic implications / S.A. Mousa -- Development and applications of animal models of thrombosis / R.J. Shebuski [and others] -- A survey of venous thrombosis models / W.P. Jeske [and others] -- Arixtra (fondaparinux sodium) / S.A. Mousa -- Oral thrombin inhibitor ximelagatran / S.A. Mousa -- Pharmacogenomics and coagulation disorders / O. Iqbal -- Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism / H. Abdel-Razeq [and others]
Control code
170925939
Dimensions
unknown
Extent
1 online resource (x, 307 pages)
Form of item
online
Isbn
9781592596584
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other control number
10.1385/1592596584
Other physical details
illustrations.
Specific material designation
remote
System control number
(OCoLC)170925939
Label
Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Highlights of latest advances in antithrombotics / S.A. Mousa -- Antiplatelet, anticoagulant, and thrombolytic drug interactions / O. Iqbal and S.A. Mousa -- Evaluation of platelet antagonists in in vitro flow models of thrombosis / O.J. McCarty [and others] -- Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases / S.A. Mousa -- Are low molecular weight heparins the same? / S.A. Mousa -- Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia / W.P. Jeske and J.M. Walenga -- Laboratory methods for heparin-induced thrombocytopenia / M. Prechel, W.P. Jeske and J.M. Walenga -- Factor Xa inhibitors / J.M. Walenga [and others] -- Tissue factor/VIIa in thrombosis and cancer / S.A. Mousa -- Tissue factor pathway inhibitor in thrombosis and beyond / S.A. Mousa [and others] -- Cell adhesion molecules: potential therapeutic and diagnostic implications / S.A. Mousa -- Development and applications of animal models of thrombosis / R.J. Shebuski [and others] -- A survey of venous thrombosis models / W.P. Jeske [and others] -- Arixtra (fondaparinux sodium) / S.A. Mousa -- Oral thrombin inhibitor ximelagatran / S.A. Mousa -- Pharmacogenomics and coagulation disorders / O. Iqbal -- Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism / H. Abdel-Razeq [and others]
Control code
170925939
Dimensions
unknown
Extent
1 online resource (x, 307 pages)
Form of item
online
Isbn
9781592596584
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other control number
10.1385/1592596584
Other physical details
illustrations.
Specific material designation
remote
System control number
(OCoLC)170925939

Library Locations

    • Ellis LibraryBorrow it
      1020 Lowry Street, Columbia, MO, 65201, US
      38.944491 -92.326012
Processing Feedback ...